Factors Associated with Preclinical Disability and Frailty Among HIV-infected and HIV-uninfected Women in the Era of CART

Overview

Journal J Womens Health (Larchmt)

Specialty Gynecology & Obstetrics

Date 2010 Jan 5

PMID 20044858

Citations 66

Authors

Arpi S Terzian

Susan Holman

Niyati Nathwani

Esther Robison

Kathleen Weber

Mary Young

Ruth M Greenblatt

Stephen J Gange

Affiliations

Soon will be listed here.

Abstract

Background: HIV-associated immune injury is hypothesized to increase the risk of preclinical disability and frailty via inflammatory pathways. We investigated the role of CD4+ T cell depletion and clinical AIDS on preclinical disability and frailty in HIV-positive women with a history of combination antiretroviral therapy (cART) and HIV-negative women.

Methods: This was a cross-sectional study nested within the Women's Interagency HIV Study (WIHS), a prospective cohort study initiated in 1994 across five U.S. cities. Questionnaires and tests were performed by 573 HIV-negative and 1206 HIV-positive women. Prevalence ratios were computed using regression models.

Results: Severe CD4+ cell depletion was an independent predictor of slowness, weakness, and frailty in HIV-positive women compared with HIV-negative women. Women with CD4+ counts<100 cells/mm3 were 0.13 seconds slower to complete 4 meters (95% CI 0.06-0.21), 1.25 kg weaker (95% CI -2.31--0.19), and had 2.7 times higher prevalence of frailty (95% CI 1.46-5.01).

Conclusions: This study is one of the largest studies to administer performance-based tests to investigate disability and frailty in HIV-positive women. HIV-positive women with intact immune systems and without a history of clinical AIDS were no different from HIV-negative women on tests of slowness, weakness, and frailty phenotype.

Citing Articles

Sex differences in epigenetic ageing for older people living with HIV.

Johnston C, Pang A, Siegler E, Thomas C, Burchett C, Crowley M EBioMedicine. 2025; 113:105588.

PMID: 39923742 PMC: 11849644. DOI: 10.1016/j.ebiom.2025.105588.

Immune profiles of pre-frail people living with HIV-1: a prospective longitudinal study.

Kundura L, Cezar R, Gimenez S, Pastore M, Reynes C, Sotto A Immun Ageing. 2024; 21(1):20.

PMID: 38481213 PMC: 10935995. DOI: 10.1186/s12979-024-00416-5.

Epigenetic Aging and Musculoskeletal Outcomes in a Cohort of Women Living With HIV.

Shiau S, Zumpano F, Wang Z, Shah J, Tien P, Ross R J Infect Dis. 2024; 229(6):1803-1811.

PMID: 38366369 PMC: 11175700. DOI: 10.1093/infdis/jiae016.

Frailty assessment: An emerging concept in aged People Living with HIV (PLHIV).

Mehta A, Halder S, Pandit S, Anuradha S J Family Med Prim Care. 2024; 12(12):3149-3155.

PMID: 38361903 PMC: 10866237. DOI: 10.4103/jfmpc.jfmpc_600_23.

To Be Frail or Not to Be Frail: This Is the Question-A Critical Narrative Review of Frailty.

Sciacchitano S, Carola V, Nicolais G, Sciacchitano S, Napoli C, Mancini R J Clin Med. 2024; 13(3).

PMID: 38337415 PMC: 10856357. DOI: 10.3390/jcm13030721.

References

Bacon M, von Wyl V, Alden C, Sharp G, Robison E, Hessol N . The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005; 12(9):1013-9. PMC: 1235804. DOI: 10.1128/CDLI.12.9.1013-1019.2005. View

. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992; 41(RR-17):1-19. View

Rantanen T, Volpato S, Ferrucci L, Heikkinen E, Fried L, Guralnik J . Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc. 2003; 51(5):636-41. DOI: 10.1034/j.1600-0579.2003.00207.x. View

Vasto S, Candore G, Balistreri C, Caruso M, Colonna-Romano G, Grimaldi M . Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev. 2006; 128(1):83-91. DOI: 10.1016/j.mad.2006.11.015. View

Barkan S, Melnick S, Preston-Martin S, Weber K, Kalish L, Miotti P . The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology. 1998; 9(2):117-25. View

Kohli R, Klein R, Schoenbaum E, Anastos K, Minkoff H, Sacks H . Aging and HIV infection. J Urban Health. 2006; 83(1):31-42. PMC: 2258332. DOI: 10.1007/s11524-005-9005-6. View

Desquilbet L, Jacobson L, Fried L, Phair J, Jamieson B, Holloway M . HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007; 62(11):1279-86. DOI: 10.1093/gerona/62.11.1279. View

Spiegelman D, Hertzmark E . Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162(3):199-200. DOI: 10.1093/aje/kwi188. View

Ainsworth B, Haskell W, Whitt M, Irwin M, Swartz A, Strath S . Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000; 32(9 Suppl):S498-504. DOI: 10.1097/00005768-200009001-00009. View

10.

Kovaiou R, Grubeck-Loebenstein B . Age-associated changes within CD4+ T cells. Immunol Lett. 2006; 107(1):8-14. DOI: 10.1016/j.imlet.2006.07.006. View

11.

Margolick J, Gange S, Detels R, OGorman M, Rinaldo Jr C, Lai S . Impact of inversion of the CD4/CD8 ratio on the natural history of HIV-1 infection. J Acquir Immune Defic Syndr. 2006; 42(5):620-6. DOI: 10.1097/01.qai.0000223028.55080.9d. View

12.

Cesari M, Penninx B, Pahor M, Lauretani F, Corsi A, Williams G . Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004; 59(3):242-8. DOI: 10.1093/gerona/59.3.m242. View

13.

Fried L, Ferrucci L, Darer J, Williamson J, Anderson G . Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004; 59(3):255-63. DOI: 10.1093/gerona/59.3.m255. View

14.

Schneider M, Gange S, Williams C, Anastos K, Greenblatt R, Kingsley L . Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS. 2005; 19(17):2009-18. DOI: 10.1097/01.aids.0000189864.90053.22. View

15.

Walston J, McBurnie M, Newman A, Tracy R, Kop W, Hirsch C . Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med. 2002; 162(20):2333-41. DOI: 10.1001/archinte.162.20.2333. View

16.

Sodora D, Silvestri G . Immune activation and AIDS pathogenesis. AIDS. 2008; 22(4):439-46. DOI: 10.1097/QAD.0b013e3282f2dbe7. View

17.

Penninx B, Kritchevsky S, Newman A, Nicklas B, Simonsick E, Rubin S . Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc. 2004; 52(7):1105-13. DOI: 10.1111/j.1532-5415.2004.52308.x. View

18.

Guralnik J, Simonsick E, Ferrucci L, Glynn R, Berkman L, Blazer D . A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994; 49(2):M85-94. DOI: 10.1093/geronj/49.2.m85. View

19.

Hessol N, Schneider M, Greenblatt R, Bacon M, Barranday Y, Holman S . Retention of women enrolled in a prospective study of human immunodeficiency virus infection: impact of race, unstable housing, and use of human immunodeficiency virus therapy. Am J Epidemiol. 2001; 154(6):563-73. DOI: 10.1093/aje/154.6.563. View

20.

Casau N . Perspective on HIV infection and aging: emerging research on the horizon. Clin Infect Dis. 2005; 41(6):855-63. DOI: 10.1086/432797. View